CSC has a suppressive influence on NK cell activity; the Fas ligand is one of the responsible for tumor-associated NK cells' decreased cytotoxicity. In addition to this, loss of mRNA for granzyme B and lack of CD16 and its associated zeta chain plus NF-κB activation also contribute. This evidence concerns the gene NFKB1 and neoplasm.